𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cyclin D3 action in androgen receptor regulation and prostate cancer

✍ Scribed by Olshavsky, N A; Groh, E M; Comstock, C E S; Morey, L M; Wang, Y; Revelo, M P; Burd, C; Meller, J; Knudsen, K E


Book ID
110072962
Publisher
Nature Publishing Group
Year
2007
Tongue
English
Weight
415 KB
Volume
27
Category
Article
ISSN
0950-9232

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Molecular regulation of androgen action
✍ Scott M. Dehm; Donald J. Tindall πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 178 KB

## Abstract Androgens are critical regulators of prostate differentiation and function, as well as prostate cancer growth and survival. Therefore, androgen ablation is the preferred systemic treatment for disseminated prostate cancer. Androgen action is exerted in target tissues via binding the and

Androgen receptor action in hormone-depe
✍ Irina U. Agoulnik; Nancy L. Weigel πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 177 KB

## Abstract The importance of androgens and androgen receptors (AR) in primary prostate cancer is well established. Metastatic disease is usually treated with some form of androgen ablation, which is effective for a limited amount of time. The role of AR in prostate cancers that recur despite andro

Androgen receptor and caveolin-1 in pros
✍ Nigel Bennett; John D. Hooper; C. Soon Lee; Glenda C. Gobe πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 243 KB

## Abstract The androgen receptor (AR) is involved in the development and maintenance of the normal prostate and the development and progression of prostate cancer (PCa). Caveolin‐1 (cav‐1) is an AR co‐regulator. The expression of this integral membrane protein is upregulated in PCa and correlates

Androgen receptor and caveolin-1 in pros
✍ Nigel Bennett; John D. Hooper; C. Soon Lee; Glenda C. Gobe πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 98 KB

## Abstract Flow diagram of androgen, androgen receptor and caveolin‐1 activity. See Androgen Receptor and Caveolin‐1 in Prostate Cancer by Bennett et al., pp. 961–970.